Page 334 - Read Online

Flynn et al. J Cancer Metastasis Treat 2019;5:43 I http://dx.doi.org/10.20517/2394-4722.2019.13 Page 11 of 12

28. Hawley TS, Riz I, Yang W, Wakabayashi Y, Depalma L, et al. Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant
myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1. Am J Hematol 2013;88:265-72.
29. Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, et al. Colon cancer stem cells dictate tumor growth and resist cell death
by production of interleukin-4. Cell Stem Cell 2007;1:389-402.
30. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, et al. Association of reactive oxygen species levels and radioresistance in cancer stem
cells. Nature 2009;458:780-3.
31. Zou Z, Yuan Z, Zhang Q, Long Z, Chen J, et al. Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer
cells. Autophagy 2012;8:1798-810.
32. White E, Mehnert JM, Chan CS. Autophagy, metabolism, and cancer. Clin Cancer Res 2015;21:5037-46.
33. Rogov V, Dotsch V, Johansen T, Kirkin V. Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis
for selective autophagy. Mol Cell 2014;53:167-78.
34. Galluzzi L, Pietrocola F, Bravo-San Pedro JM, Amaravadi RK, Baehrecke EH, et al. Autophagy in malignant transformation and cancer
progression. EMBO J 2015;34:856-80.
35. Thorburn A, Thamm DH, Gustafson DL. Autophagy and cancer therapy. Mol Pharmacol 2014;85:830-8.
36. Kimmelman AC. The dynamic nature of autophagy in cancer. Genes Dev 2011;25:1999-2010.
37. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1.
Nature 1999;402:672-6.
38. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient
tumor suppressor. Proc Natl Acad Sci U S A 2003;100:15077-82.
39. Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy
gene. J Clin Invest 2003;112:1809-20.
40. Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, et al. The selective autophagy substrate p62 activates the stress responsive
transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 2010;12:213-23.
41. Lau A, Wang XJ, Zhao F, Villeneuve NF, Wu T, et al. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct
interaction between Keap1 and p62. Mol Cell Biol 2010;30:3275-85.
42. Villeneuve NF, Lau A, Zhang DD. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into
cullin-ring ubiquitin ligases. Antioxid Redox Signal 2010;13:1699-712.
43. Hayes JD, McMahon M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci
2009;34:176-88.
44. Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, et al. Autophagy suppresses tumor progression by limiting chromosomal
instability. Genes Dev 2007;21:1367-81.
45. Liu EY, Xu N, O'Prey J, Lao LY, Joshi S, et al. Loss of autophagy causes a synthetic lethal deficiency in DNA repair. Proc Natl Acad Sci
U S A 2015;112:773-8.
46. Gillespie DA, Ryan KM. Autophagy is critically required for DNA repair by homologous recombination. Mol Cell Oncol
2016;3:e1030538.
47. Massague J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature 2016;529:298-306.
48. Wyckoff JB, Jones JG, Condeelis JS, Segall JE. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer
Res 2000;60:2504-11.
49. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563-72.
50. Janji B, Viry E, Moussay E, Paggetti J, Arakelian T, et al. The multifaceted role of autophagy in tumor evasion from immune surveillance.
Oncotarget 2016;7:17591-607.
51. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, et al. Autophagy promotes tumor cell survival and restricts necrosis,
inflammation, and tumorigenesis. Cancer Cell 2006;10:51-64.
52. Karantza-Wadsworth V, Patel S, Kravchuk O, Chen G, Mathew R, et al. Autophagy mitigates metabolic stress and genome damage in
mammary tumorigenesis. Genes Dev 2007;21:1621-35.
53. Fung C, Lock R, Gao S, Salas E, Debnath J. Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol
Biol Cell 2008;19:797-806.
54. Cufi S, Vazquez-Martin A, Oliveras-Ferraros C, Martin-Castillo B, Vellon L et al. Autophagy positively regulates the CD44(+) CD24(-/
low) breast cancer stem-like phenotype. Cell Cycle 2011;10:3871-85.
55. Vera-Ramirez L, Vodnala SK, Nini R, Hunter KW, Green JE. Autophagy promotes the survival of dormant breast cancer cells and
metastatic tumour recurrence. Nat Commun 2018;9:1944.
56. Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev
Immunol 2007;7:41-51.
57. Kortylewski M, Kujawski M, Wang T, Wei S, Zhang S et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent
antitumor immunity. Nat Med 2005;11:1314-21.
58. Baginska J, Viry E, Berchem G, Poli A, Noman MZ et al. Granzyme B degradation by autophagy decreases tumor cell susceptibility to
natural killer-mediated lysis under hypoxia. Proc Natl Acad Sci U S A 2013;110:17450-5.
59. Viry E, Baginska J, Berchem G, Noman MZ, Medves S et al. Autophagic degradation of GZMB/granzyme B: a new mechanism of
hypoxic tumor cell escape from natural killer cell-mediated lysis. Autophagy 2014;10:173-5.
60. Taylor MA, Parvani JG, Schiemann WP. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth
factor-beta in normal and malignant mammary epithelial cells. J Mammary Gland Biol Neoplasia 2010;15:169-90.
61. Ricciardi M, Zanotto M, Malpeli G, Bassi G, Perbellini O et al. Epithelial-to-mesenchymal transition (EMT) induced by inflammatory
priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells. Br J Cancer 2015;112:1067-75.